Targeting human breast tumour in xeno-grafted scid mice with 99tcm-glucarate

Nuclear Medicine Communications

Volumn 18, Issue 3, 1997, Pages 241-251

  Petrov, A D ^a   Narula, J ^a,b   Nakazawa, A ^a   Khaw, B A ^a,b,c  

^a NORTHEASTERN UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c MOLECULAR TARGETING TECHNOLOGIES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MONOCLONAL ANTIBODY IN 111; PENTETATE TECHNETIUM TC 99M; SACCHARIC ACID;

ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; CANCER SCINTISCANNING; CONTROLLED STUDY; DRUG UPTAKE; HUMAN; HUMAN CELL; MOUSE; TUMOR XENOGRAFT;

EID: 0030896857     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199703000-00008     Document Type: Article

References (38)

1. Cotran RS, Kumar V, Robbins SL Pathologic basis of disease, 5th edn. Philadelphia, PA: W. B. Saunders, 1994: 1099.
2. Kotz D. Scintimammaography: Magic bullet or false promise? I Nucl Med 1995; 36:15N-20N.
3. Lastoria S, Varrella P, Mainolfi C et al. Technctium-99m-sestamibi scintigraphy in the diagnosis of primary breast cancer (abstract). J Nucl Med 1994; 35(suppl.):22P.
4. Leveille J, Pison C, Karakand Y, Lemicux R, Vallieres B. Technetium-99m glucoheptonate in brain-tumor detection: An important advance in radiotracer technique. J Nucl Med 1977;18: 957-961.
5. Vorne M, Alanko K, Jarvi K et al. Comparison of gallium-67 citrate and technetium-99m glucohcptonate in the evaluation of pulmonary malignancies. J Nucl Ma11987; 28: 442-446.
6. Piccolo S, Lastoria S, Mainolfi C et al. Technetium-99m-methylene diphosphonate scintimammography to image primary breast cancer. J Nucl Med 1995; 36: 718-724.
7. Haberkorn U, Strauss LG, Reisser Ch et al. Glucose uptake, perfusion, and cell proliferation in head and neck tumors: Relation of positron emission tomography to flow cytometry. J Nucl Med 1991;32:1548-1555.
8. Sehweil AM, McKillop JH, Milroy R et al. Thallium-201 scintigraphy in the staging of lung cancer, breast cancer and lymphoma. Nucl Med Commun 1990;11:263-269.
9. Day ED, Paninsek JA, Pressman D. Specific localization in vivo of antihepatoma antibodies in autochthonous rat hepatomas. J Natl Caliccr Inst 1961;27:1107-1114.
10. Goldenberg DM, Preston DF, Primus FJ, Hansen HJ. Photoscan localization of GW-39 tumors in hamsters using radio-labeled anticarcinoembryonic antigen immunoglobulin G. Cancer Res 1974; 34:1-9.
11. Goldenberg DM, De Land FH, Kim EE et al. Use of radio-labeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. N Engl Med 1978; 298: 1384-1388.
12. Goldenberg DM, Kim EE, De Land FN, van Nagel JR. Clinical radioimmunodctection of cancer with radioactive antibodies to human chorionic gonadotropin. Science 1980; 208: 1284-1286.
13. Mach J-P, Carrel S, Forni M, Ritschard J, Donatti A, Alberto P. Tumor localization of radiolabeled antibodies against carcinoembryonic antigen in patients with carcinoma. N Engl Med 1980; 303: 5-10.
14. Larson SM, Carrasquillo JA, McGuffin D et al. Use of 1-131 labeled, murine Fab against a high molecular weight antigen of human melanoma: Preliminary experience. Radiology 1985; 155: 487-492.
15. Carrasquillo JA, Bunn PA, Jr, Keenan AM et al. Radioim munodetection of cutaneous T-ccll lymphoma with In-111-labclcd T101 monoclonal antibody. N Engl J Med 1986; 315: 673-680.
16. Pak KY, Nedelman MA, Daddona PE. Visualization of experimental tumor model: Application of a new Tc-99m-labeled compound. J Nucl Med 1989; 30: 906.
17. Edgington TS, Soule HR, Linder E, Bacchi C, Khaw BA, Haber E. The 126 kD phosphoprotein of human breast carcinoma cell surface. Protides of the Biological Fluids 1983; 31: 541-545.
18. Soule HR, Linder E, Edgington T. Membrane 126-kilo-dalton phosphoglycoprotein associated with human carcinomas identified by a hybridoma antibody to mammary carcinoma cells. Proc Natl Acad Sci 1983; 80:1332-1336.
19. Mandell G A, Herrick WC, Harcke HT, Sharkey C, Brooks KM, MacEwen GD. Neurofibromas: Location by scanning with Tc-99m-DTPA. Radiology 1985; 157: 803-806.
20. Krejcarek GE, Tucker KL. Covalent attachment of chelating groups to macromolecules. Biochem Biophys Res Comm 1977; 77: 581-585.
21. Tyler DD, Gonze J. The preparation of heart mitochondrion from laboratory animals Mcth Etizymol 1967;10: 75-77.
22. 2+ uptake coupled to electron transport in rat heart mitochondria. J Biol Chem 1978; 253: 6379-6385.
23. Yaoita H, Fischman AJ, Wilkinson R, Khaw BA, Juweid M, Strauss HW. Distribution of deoxyglycose and technetium-99m-glucarate in the acutely ischemic myocardium. J Nucl Med 1993; 34:1303-1308.
24. Ohtani H, Callahen RJ, Khaw BA, Fishman AJ, Wilkinson RA, Strauss HW. Comparison of technetium-99m-glucarate and thallium-201 for the identification of acute myocardial infarction in rats. J Nucl Med 1992; 33:1988-1993.
25. Khaw BA, Pak KY, Ahmad M, Nossif ND, Strauss HW. Visualization of experimental cerebral infarct: Application of a new Tc-99m-labeled compound. Circulation 1985; 78(suppl.2):140.
26. Yaoita H, Uehara T, Brownell AL et al. Localization of tech-netium-99m-glucarate in zones of acute cerebral injury. J Nucl Med 1991;32: 272-278.
27. Ten Kate CL, Fischman AJ, Wilkinson RA et al. Tc-99m-glu-caric acid: A glucose analogue (abstract). Eur J Nucl Med 1990;17: 451.
28. Khaw BA, Strauss HW, Cahill SL, Soule HR, Edgington T, Cooney J. Sequential imaging of indium-111-labeled monoclonal antibody in human mammary tumors hosted in nude mice. J Nucl Med 1984; 25: 592-603.
29. Khaw BA, Cooney J, Edgington T, Strauss HW. Differences in experimental tumor localization of dual-labeled monoclonal antibody. J Nucl Med 1986; 27:1293-1299.
30. Crane PD, Onthank DC, Bourque C et al. Autoradiography and radioscintigraphy of technetium-99m-sestamibi in c-neu transgenic mice. J Nud Med 1995; 36:1862-1868.
31. Nicol PD, Khaw BA. Monoclonal antibody imaging. In: Marcus ML, Schelbert HR, Scorton DJ, Wolf GL, eds. Cardiac imaging: Companion to Braunwald's heart disease. Philadelphia, PA: W. B. Saunders, 1991: 1110.
32. Narula J, Petrov A, Pak KY et al. Very early noninvasive detection of acute experimental non-reperfused myocardial infarction with technetium-99m-labeled glucarate. Circulation (in press).
33. Molea N, Lazzeri E, Bodei L et al. Preliminary biodistribution and pharmacokinetic studies of Tc-99m-glucaric acid in humans. J Nucl Biol Med 1994; 38: 279-280.
34. Marsh CA. Metabolism of D-glucuronolactone in mammalian systems: Identification of D-glucaric acid as a normal constituent of urine. Biochetn J 1963; 86: 77-86.
35. Marsh CA. Metabolism of D-glucuronolactone in mammalian systems. 2. Conversion of D-glucuronolactone into d-glucaric acid by tissue preparations. Biochem J 1963; 87: 82-90.
36. Walaszek Z, Hanausek-Walaszek M, Minton JP., Webb TE. Dietary glucarate as antipromoter of 7,12-dimethylbenz (a) anthracene induced mammary tumorogenesis. Carcinogenesis 1986; 7:1463-1466.
37. Walaszek Z. Potential use of D-glucaric acid derivatives in cancer prevention. Caiiccr Lett 1990; 54:1-8.
38. Dwivedi C, Orcdipe OA, Barth RF, Downie AA, Webb TE. Effects of the experimental chemopreventative agent, glucarate, on intestinal carcinogenesis in rats. Carcinogenesis 1989;10:1539-1541.